← Back to Compliance
NAMs Validation Checklist
Validating New Approach Methodologies for regulatory acceptance requires demonstrating fitness-for-purpose across multiple dimensions. This checklist covers the key criteria used by FDA, EMA, OECD, and other regulatory bodies to evaluate NAMs.
The 3Rs Framework: NAMs validation aligns with Replacement, Reduction, and Refinement principles. Your validation package should clearly articulate how the NAM addresses one or more of these objectives.
1. Relevance Assessment
Biological Relevance - Does the NAM recapitulate the biology of the target organ/system?
Mechanistic Basis - Is the mechanism of action well-characterized and documented?
Human Relevance - Does the NAM use human cells/tissues providing human-relevant data?
Context of Use - Is the intended regulatory application clearly defined?
Endpoint Relevance - Are measured endpoints relevant to the regulatory question?
2. Reliability Assessment
Intra-laboratory Reproducibility - Consistent results within the same laboratory over time
Inter-laboratory Reproducibility - Consistent results across different laboratories
Defined Protocol - Detailed, transferable standard operating procedures
Quality Controls - Positive and negative controls with acceptance criteria
Reference Compounds - Testing with known positive/negative reference chemicals
3. Technical Characterization
Cell Source Documentation - Origin, authentication, passage limits, quality criteria
Platform Specifications - Device materials, dimensions, flow parameters
Culture Conditions - Media composition, environmental parameters, duration
Analytical Methods - Validated readout methods with performance characteristics
Data Analysis - Statistical methods and acceptance criteria
4. Predictive Capacity
Sensitivity - Ability to correctly identify positive responses
Specificity - Ability to correctly identify negative responses
Accuracy - Overall concordance with reference data
Domain of Applicability - Defined chemical/biological space where NAM is valid
Limitations - Known limitations and exclusion criteria documented
5. Documentation Package
Validation Report - Comprehensive study report following regulatory format
SOPs - Complete standard operating procedures
Raw Data - Access to underlying data for regulatory review
Peer Review - Published literature supporting the NAM
Regulatory History - Previous regulatory interactions or submissions
Regulatory Submission Tips
- Early Engagement - Request pre-submission meetings to discuss validation strategy
- Gap Analysis - Identify and address validation gaps before submission
- Fit-for-Purpose - Validation depth should match the regulatory decision being supported
- Weight of Evidence - Multiple lines of evidence strengthen the validation package
- Transparency - Clearly state limitations and uncertainties
© 2025 Patient Analog. All rights reserved.
Educational content created by J Radler for the biotech and scientific community. Last updated: February 4, 2026.
Free to share for educational purposes with attribution.